Skip to main content

Urinary zinc excretion in Crohn's disease

Abstract

In order to study the reliability of urinary zinc levels as an index of zinc metabolism and status in Crohn's disease, we evaluated plasma and urinary zinc concentrations, urinary 3-methylhistidine excretion, and Crohn's disease activity index (CDAI) in 42 patients affected by Crohn's disease. Plasma zinc correlated directly with albuminemia (P=0.01) and inversely with CDAI (P=0.001). Urinary zinc excretion correlated directly with urinary 3-methylhistidine (P=0.001) and plasma zinc levels (P=0.01), and inversely with CDAI (P=0.05). However, from multiple regression analysis, it was found that zincemia is influenced by CDAI and not by albumin, whereas zincuria is related to urinary 3-methylhistidine and plasma zinc, and not to CDAI. Our conclusion is that, in Crohn's disease, zincuria can be an index of zinc status when used together with measurements of lean body mass and turnover and factors influencing plasma ultrafiltrable zinc fraction.

This is a preview of subscription content, access via your institution.

References

  1. Solomons NW, Rosenberg IH, Sanstead HH, Vo-Khactu KP: Zinc deficiency in Crohn's disease. Digestion 16:87–95, 1977

    Google Scholar 

  2. McClain C, Soutor C, Zieve L: Zinc deficiency: A complication of Crohn's disease. Gastroenterology 78:272–297, 1980

    Google Scholar 

  3. Nishi Y, Lifshits F, Bayne MA, Daum F, Silverberg M, Aiges H: Zinc status and its relation to growth retardation in children with chronic inflammatory bowel disease. Am J Clin Nutr 33:2613–2621, 1980

    Google Scholar 

  4. Sturniolo GC, Molokhia MM, Shields R, Tunberg LA: Zinc absorption in Crohn's disease. Gut 21:387–391, 1980

    Google Scholar 

  5. Fleming CR, Huizega KA, McCall JT, Gildea J, Dennis R: Zinc nutrition in Crohn's disease. Dig Dis Sci 26:865–870, 1981

    Google Scholar 

  6. Main ANH, Hall MJ, Russell RI, Fell GS, Mills PR, Shenkin A: Clinical experience of zinc supplementation during intravenous nutrition in Crohn's disease: value of serum and urine measurements. Gut 23:984–991, 1982

    Google Scholar 

  7. Mills PR, Fell GS: Zinc and inflammatory bowel disease. Am J Clin Nutr 32:2172–2173, 1979

    Google Scholar 

  8. Long CL, Haverberg LN, Young VR, Kinney JM, Munro HN, Geiger JW: Metabolism 24:929–935, 1975

    Google Scholar 

  9. Long CI, Birkhan RN, Geiger JW, Betts JE, Sciller WR, Blakemore WS: Urinary excretion of 3-methylhistidine: An assessment of muscle protein catabolism in adult normal subjects and during malnutrition, sepsis and skeletal trauma. Metabolism 30:765–776, 1981

    Google Scholar 

  10. Best WR, Becktel JM, Singleton JW, Kern F Jr: Development of a Crohn's disease activity index: National Cooperative Crohn's Disease Study. Gastroenterology 70:439–444, 1976

    Google Scholar 

  11. Nie H, Hull CH, Jenkin JG, Steinbrenner K, Bent DH: Statistical Package for Social Sciences, 2nd ed. New York, McGraw-Hill, 1975

    Google Scholar 

  12. Kiilerich S, Christensen MS, Naestoft J, Cristiansen C: Determination of zinc in serum and urine by atomic absorption spectrophotometry; relationship between serum levels of zinc and proteins in 104 normal subjects. Clin Chim Acta 105:231–239, 1980

    Google Scholar 

  13. Pekarek RS, Beisel WR: Characterization of the endogenous mediator(s) of serum zinc and iron depression during infection and other stresses. Proc Soc Exp Biol Med 138:728–731, 1971

    Google Scholar 

  14. Wannemacher RW Jr, Pekarek RS, Klainer AS, Bertelloni PJ, DuPont HL, Hornick RB, Beisel WR: Detection of a leukocytic endogenous mediator-like mediator of serum amino acid and zinc depression during various infectious illnesses. Infect Immun 11:873–875, 1975

    Google Scholar 

  15. Solomons NW, Elson CO, Pekarek RS, Jacob RA, Sandstead HM, Rosenberg IH: Leucocytic endogenous mediator in Crohn's disease. Immun Infect 22:637–639, 1978

    Google Scholar 

  16. Young VR, Alexis SD, Baliga BS, Munro HN, Mueke W: Metabolism of administered 3-methylhistidine: Lack of muscle transfer ribonucleic acid charging and quantitative excretion as 3-methylhistidine and itsN-acetyl derivate. J Biol Chem 247:3592–3600, 1972

    Google Scholar 

  17. Lukaski H, Mendez J: Relationship between fat-free weight and urinary 3-methylhistidine excretion in man. Metabolism 29:758–761, 1980

    Google Scholar 

  18. Young VR, Munro HN:N 7-Methylhistidine (3-methylhistidine) and muscle protein turnover: An overview. Fed Proc 37:2291–2300, 1978

    Google Scholar 

  19. Giroux EL, Henkin RI: Competition for zinc among serum albumin and amino acid. Biochim Biophys Acta 273:64–72, 1971

    Google Scholar 

  20. Prasad AS, Oberleas D: Binding of zinc to amino acids and to serum proteinsin vitro. J Lab Clin Med 76:416–425, 1970

    Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Pironi, L., Miglioli, M., Cornia, G.L. et al. Urinary zinc excretion in Crohn's disease. Digest Dis Sci 32, 358–362 (1987). https://doi.org/10.1007/BF01296288

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01296288

Key Words

  • zinc
  • Crohn's disease
  • Crohn's disease activity index